Issues lobbied + lobbyists
HCR — Health Issues
Issues related to mental health. Monitored Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization. Issues related to pharmacy benefit management, including alternative funding programs. Monitored issues related to healthcare workforce shortages. Issues related to drug pricing. Issues related to ingredient safety.
Government entities lobbied: Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; White House Office
MMM — Medicare/Medicaid
Implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. Issues related to Most Favored Nation drug pricing.
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE
TAX — Taxation/Internal Revenue Code
Monitor implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes.
BNK — Bankruptcy
Issues related to litigation reform.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
TRD — Trade (domestic/foreign)
Issues related to tariffs.
Government entities lobbied: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE; White House Office